John M. Leonard, President and CEO: Intellia Therapeutics NTLA Sell · Filed 01/07

Trade details

Type: Insider sale
Amount: $314,484.66
Shares · price: 34,146 sh · $9.21 a share
Held after: 1,013,339 sh
Stock: Intellia Therapeutics NTLA
Person: John M. LeonardPresident and CEO
Trade date: 26/01/05
Filed: 26/01/07
Days to filing: 2 days

Sold 3.3% of holdings

Share of holding sold: 3.3%

Intellia Therapeutics trades, last 26 weeks

What else happened in Intellia Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/06~02/04

John M. Leonard's recent trades

John M. LeonardOfficer, Director
Planned sale10b5-1 planIntellia Therapeutics
Planned sale10b5-1 plan
Intellia Therapeutics
NTLA
$293.6K
22,675 sh
$293.6K
Filed 08/20
Traded 08/20
John M. LeonardPresident and CEO
Sell10b5-1 planIntellia Therapeutics
Sell10b5-1 plan
Intellia Therapeutics
NTLA
$474.1K
49,959 sh
$474.1K
Filed 25/12/12
Traded 25/12/11
John M. LeonardPresident and CEO
Sell10b5-1 planIntellia Therapeutics
Sell10b5-1 plan
Intellia Therapeutics
NTLA
$310.9K
32,832 sh
$310.9K
Filed 25/12/12
Traded 25/12/11
John M. LeonardPresident and CEO
Sell10b5-1 planIntellia Therapeutics
Sell10b5-1 plan
Intellia Therapeutics
NTLA
$51.4K
5,355 sh
$51.4K
Filed 25/12/12
Traded 25/12/11
John M. LeonardOfficer, Director
Planned sale10b5-1 planIntellia Therapeutics
Planned sale10b5-1 plan
Intellia Therapeutics
NTLA
$822.4K
88,146 sh
$822.4K
Filed 25/12/11
Traded 25/12/11